These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 37540934)

  • 1. The effect of botulinum toxin on anxiety in cervical dystonia: A prospective, observational study.
    Sugar D; Patel R; Comella C; González DA; Gray G; Stebbins GT; Mahajan A
    Parkinsonism Relat Disord; 2023 Sep; 114():105792. PubMed ID: 37540934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum toxin type B vs. type A in toxin-naïve patients with cervical dystonia: Randomized, double-blind, noninferiority trial.
    Pappert EJ; Germanson T;
    Mov Disord; 2008 Mar; 23(4):510-7. PubMed ID: 18098274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized study of botulinum toxin versus botulinum toxin plus physical therapy for treatment of cervical dystonia.
    Hu W; Rundle-Gonzalez V; Kulkarni SJ; Martinez-Ramirez D; Almeida L; Okun MS; Wagle Shukla A
    Parkinsonism Relat Disord; 2019 Jun; 63():195-198. PubMed ID: 30837195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin type B for cervical dystonia.
    Costa J; Espírito-Santo C; Borges A; Ferreira JJ; Coelho M; Moore P; Sampaio C
    Cochrane Database Syst Rev; 2005 Jan; (1):CD004315. PubMed ID: 15674941
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An analysis of the efficacy of botulinum neurotoxin type a in treating cervical dystonia.
    Zhou X; Li ZF; Guo XZ; Wei Q; Niu YN; Li M; Xia JN; Chen LP
    Technol Health Care; 2024; 32(4):2421-2430. PubMed ID: 38073352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin Type A Injection for Cervical Dystonia in Adults with Dyskinetic Cerebral Palsy.
    Yi YG; Kim K; Yi Y; Choi YA; Leigh JH; Bang MS
    Toxins (Basel); 2018 May; 10(5):. PubMed ID: 29772695
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeting pain in the long-term treatment of cervical dystonia with botulinum toxin A.
    Marciniec M; Szczepańska-Szerej A; Papuć E; Rejdak K
    Int J Neurosci; 2022 Oct; 132(10):1026-1030. PubMed ID: 33295845
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-responsive cervical dystonia.
    Brashear A; Lew MF; Dykstra DD; Comella CL; Factor SA; Rodnitzky RL; Trosch R; Singer C; Brin MF; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1439-46. PubMed ID: 10534248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KinesioTaping after botulinum toxin type A for cervical dystonia in adult patients.
    Dec-Ćwiek M; Porębska K; Sawczyńska K; Kubala M; Witkowska M; Zmijewska K; Antczak J; Pera J
    Brain Behav; 2022 Apr; 12(4):e2541. PubMed ID: 35238494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sensorimotor Perceptive Rehabilitation Integrated (SPRInt) program: exercises with augmented movement feedback associated to botulinum neurotoxin in idiopathic cervical dystonia-an observational study.
    Castagna A; Caronni A; Crippa A; Sciumè L; Giacobbi G; Corrini C; Montesano A; Ramella M
    Neurol Sci; 2020 Jan; 41(1):131-138. PubMed ID: 31478151
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How satisfied are cervical dystonia patients after 3 years of botulinum toxin type A treatment? Results from a prospective, long-term observational study.
    Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
    J Neurol; 2019 Dec; 266(12):3038-3046. PubMed ID: 31501975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Headache attributed to craniocervical dystonia: A prospective cohort study.
    Eugenio Ramalho Bezerra M; Sampaio Rocha-Filho PA
    Eur J Pain; 2020 Sep; 24(8):1484-1494. PubMed ID: 32422691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Botulinum toxin type A and cervical dystonia: a seven-year follow-up.
    Camargo CH; Teive HA; Becker N; Munhoz RP; Werneck LC
    Arq Neuropsiquiatr; 2011 Oct; 69(5):745-50. PubMed ID: 22042174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cumulative effects of long-term treatment with abobotulinumtoxinA in cervical dystonia: Findings from a prospective, observational study.
    Colosimo C; Charles D; Misra VP; Maisonobe P; Om S;
    J Neurol Sci; 2020 Sep; 416():117015. PubMed ID: 32682125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The clinical utility of botulinum toxin injections targeted at the motor endplate zone in cervical dystonia.
    Delnooz CC; Veugen LC; Pasman JW; Lapatki BG; van Dijk JP; van de Warrenburg BP
    Eur J Neurol; 2014 Dec; 21(12):1486-e98. PubMed ID: 25060697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Personalized botulinum toxin type A therapy for cervical dystonia based on kinematic guidance.
    Samotus O; Lee J; Jog M
    J Neurol; 2018 Jun; 265(6):1269-1278. PubMed ID: 29557988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia.
    Brin MF; Lew MF; Adler CH; Comella CL; Factor SA; Jankovic J; O'Brien C; Murray JJ; Wallace JD; Willmer-Hulme A; Koller M
    Neurology; 1999 Oct; 53(7):1431-8. PubMed ID: 10534247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent onabotulinumtoxinA treatment of cervical dystonia and concomitant migraine.
    Winner PK; Sadowsky CH; Martinez WC; Zuniga JA; Poulette A
    Headache; 2012 Sep; 52(8):1219-25. PubMed ID: 22607530
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-Dose Neubotulinum Toxin A versus Low-Dose Abobotulinum Toxin A Injection for the Treatment of Cervical Dystonia: A Multicenter, 48-Week, Prospective, Double-Blinded, Randomized Crossover Design Study.
    Kongsaengdao S; Arayawithchanont A; Samintharapanya K; Rojanapitayakorn P; Maneeton B; Maneeton N
    Toxins (Basel); 2021 Oct; 13(10):. PubMed ID: 34678987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A pilot study of botulinum toxin A for headache in cervical dystonia.
    Ondo WG; Gollomp S; Galvez-Jimenez N
    Headache; 2005 Sep; 45(8):1073-7. PubMed ID: 16109123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.